Kepler Universitatsklinikum GmbH

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia2 trials
• Heart failure2 trials
• Aortic stenosis1 trial
• Atrial fibrillation1 trial
• Coronary artery disease1 trial
• Crohn's disease1 trial
• Kidney cancer1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Stroke1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting4 trials
• Recruiting4 trials
• Completed3 trials

Lead sponsor

• Abbott Medical Devices2 trials
• Janssen Research & Development, LLC2 trials
• Biotronik SE & Co. KG1 trial
• Insel Gruppe AG, University Hospital Bern1 trial
• Ipsen1 trial
• and 4 more

Running trials

• Recruiting

  BIO|STREAM.CSP Study

  NCT07393009· Biotronik SE & Co. KG· Source

  Contact: Johannes Pfaffenberger

• Recruiting

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  NCT06852222· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

  NCT05049798· Janssen Pharmaceutica N.V., Belgium· Source

• Active, not recruiting

  Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

  NCT04788888· Abbott Medical Devices· Source

• Active, not recruiting

  The SELUTION DeNovo Study

  NCT04859985· M.A. Med Alliance S.A.· Source

• Active, not recruiting

  Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

  NCT03647878· Ipsen· Source

• Recruiting

  Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project

  NCT01252485· University of Ulm· Source

  Contact: Clemens Schmitt, Prof.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia2 recruiting
• Crohn's disease1 recruiting
• Heart failure1 recruiting

Closed trials

• Completed

  Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

  NCT05499832· Phase 3· Insel Gruppe AG, University Hospital Bern· Source

• Completed

  Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)

  NCT04590144· MicroPort CRM· Source

• Completed

  Confirm Rx Insertable Cardiac Monitor SMART Registry

  NCT03505801· Abbott Medical Devices· Source